255 related articles for article (PubMed ID: 18795228)
1. Inflammatory response in acute viral exacerbations of COPD.
Rohde G; Borg I; Wiethege A; Kauth M; Jerzinowski S; An Duong Dinh T; Bauer TT; Bufe A; Schultze-Werninghaus G
Infection; 2008 Oct; 36(5):427-33. PubMed ID: 18795228
[TBL] [Abstract][Full Text] [Related]
2. Systemic and upper and lower airway inflammation at exacerbation of chronic obstructive pulmonary disease.
Hurst JR; Perera WR; Wilkinson TM; Donaldson GC; Wedzicha JA
Am J Respir Crit Care Med; 2006 Jan; 173(1):71-8. PubMed ID: 16179639
[TBL] [Abstract][Full Text] [Related]
3. [Etiology and biomarkers of systemic inflammation in mild to moderate COPD exacerbations].
Saldías PF; Díaz PO; Dreyse DJ; Gaggero BA; Sandoval AC; Lisboa BC
Rev Med Chil; 2012 Jan; 140(1):10-8. PubMed ID: 22552550
[TBL] [Abstract][Full Text] [Related]
4. Exacerbations of chronic obstructive pulmonary disease.
Wedzicha JA; Donaldson GC
Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
[TBL] [Abstract][Full Text] [Related]
5. Local inflammation occurs before systemic inflammation in patients with COPD.
He Z; Chen Y; Chen P; Wu G; Cai S
Respirology; 2010 Apr; 15(3):478-84. PubMed ID: 20210891
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal follow-up of systemic inflammation after acute exacerbations of COPD.
Groenewegen KH; Dentener MA; Wouters EF
Respir Med; 2007 Nov; 101(11):2409-15. PubMed ID: 17644367
[TBL] [Abstract][Full Text] [Related]
7. Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease.
Valipour A; Schreder M; Wolzt M; Saliba S; Kapiotis S; Eickhoff P; Burghuber OC
Clin Sci (Lond); 2008 Oct; 115(7):225-32. PubMed ID: 18307413
[TBL] [Abstract][Full Text] [Related]
8. MMP-9, TIMP-1 and inflammatory cells in sputum from COPD patients during exacerbation.
Mercer PF; Shute JK; Bhowmik A; Donaldson GC; Wedzicha JA; Warner JA
Respir Res; 2005 Dec; 6(1):151. PubMed ID: 16372907
[TBL] [Abstract][Full Text] [Related]
9. Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study.
Rohde G; Wiethege A; Borg I; Kauth M; Bauer TT; Gillissen A; Bufe A; Schultze-Werninghaus G
Thorax; 2003 Jan; 58(1):37-42. PubMed ID: 12511718
[TBL] [Abstract][Full Text] [Related]
10. Levels of soluble triggering receptor expressed on myeloid cells 1 in infectious exacerbations of chronic obstructive pulmonary disease.
Rohde G; Radsak MP; Borg I; Buhl R; Schultze-Werninghaus G; Taube C
Respiration; 2012; 83(2):133-9. PubMed ID: 21701149
[TBL] [Abstract][Full Text] [Related]
11. A community-based, time-matched, case-control study of respiratory viruses and exacerbations of COPD.
Hutchinson AF; Ghimire AK; Thompson MA; Black JF; Brand CA; Lowe AJ; Smallwood DM; Vlahos R; Bozinovski S; Brown GV; Anderson GP; Irving LB
Respir Med; 2007 Dec; 101(12):2472-81. PubMed ID: 17822891
[TBL] [Abstract][Full Text] [Related]
12. Complement factor C5a in acute exacerbation of Chronic Obstructive Pulmonary Disease.
Marc MM; Kristan SS; Rozman A; Kern I; Flezar M; Kosnik M; Korosec P
Scand J Immunol; 2010 May; 71(5):386-91. PubMed ID: 20500690
[TBL] [Abstract][Full Text] [Related]
13. Soluble interleukin-5 receptor alpha is increased in acute exacerbation of chronic obstructive pulmonary disease.
Rohde G; Gevaert P; Holtappels G; Fransen L; Borg I; Wiethege A; Arinir U; Tavernier J; Schultze-Werninghaus G; Bachert C
Int Arch Allergy Immunol; 2004 Sep; 135(1):54-61. PubMed ID: 15286446
[TBL] [Abstract][Full Text] [Related]
14. Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease.
Aaron SD; Angel JB; Lunau M; Wright K; Fex C; Le Saux N; Dales RE
Am J Respir Crit Care Med; 2001 Feb; 163(2):349-55. PubMed ID: 11179105
[TBL] [Abstract][Full Text] [Related]
15. Changes in sputum T-lymphocyte subpopulations at the onset of severe exacerbations of chronic obstructive pulmonary disease.
Tsoumakidou M; Tzanakis N; Chrysofakis G; Kyriakou D; Siafakas NM
Respir Med; 2005 May; 99(5):572-9. PubMed ID: 15823454
[TBL] [Abstract][Full Text] [Related]
16. Association between cytokines in induced sputum and severity of chronic obstructive pulmonary disease.
Hacievliyagil SS; Gunen H; Mutlu LC; Karabulut AB; Temel I
Respir Med; 2006 May; 100(5):846-54. PubMed ID: 16214322
[TBL] [Abstract][Full Text] [Related]
17. Oxidative stress and airway inflammation in severe exacerbations of COPD.
Drost EM; Skwarski KM; Sauleda J; Soler N; Roca J; Agusti A; MacNee W
Thorax; 2005 Apr; 60(4):293-300. PubMed ID: 15790984
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory changes, recovery and recurrence at COPD exacerbation.
Perera WR; Hurst JR; Wilkinson TM; Sapsford RJ; Müllerova H; Donaldson GC; Wedzicha JA
Eur Respir J; 2007 Mar; 29(3):527-34. PubMed ID: 17107990
[TBL] [Abstract][Full Text] [Related]
19. [Changes of anaphylatoxin C5a in chronic obstructive pulmonary disease and the relationship with systemic and local inflammation].
Zhang J; Yao WZ; Sun YC
Zhonghua Jie He He Hu Xi Za Zhi; 2008 May; 31(5):356-9. PubMed ID: 18953960
[TBL] [Abstract][Full Text] [Related]
20. Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levels.
Wedzicha JA; Seemungal TA; MacCallum PK; Paul EA; Donaldson GC; Bhowmik A; Jeffries DJ; Meade TW
Thromb Haemost; 2000 Aug; 84(2):210-5. PubMed ID: 10959691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]